ADC Therapeutics SA Analysis
| Analyst Ratings |
|
Average Target Price
|
13.71
|
|
Average Rating
|
3.88
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
2
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.13
|
0.00
|
0.13
|
100.00%
|
|
2022-12-31
|
-0.52
|
0.00
|
0.52
|
100.00%
|
|
2022-09-30
|
-0.35
|
-0.65
|
-0.30
|
-85.71%
|
|
2022-06-30
|
-0.91
|
-0.84
|
0.07
|
7.69%
|
|
2022-03-31
|
-0.70
|
-0.22
|
0.48
|
68.57%
|
|
2021-12-31
|
-0.86
|
-0.45
|
0.41
|
47.67%
|
|
2021-09-30
|
-0.92
|
-0.93
|
-0.01
|
-1.09%
|
|
2021-06-30
|
-0.86
|
-0.95
|
-0.09
|
-10.47%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.00
|
|
2022-09-30
|
-2.16
|
|
2021-09-30
|
-3.28
|
|
2020-09-30
|
-4.75
|